Trial Profile
Vildagliptin on glycemic control in newly diagnosed type 2 diabetes in the short-term insulin pump therapy and remission: a prospective, randomized, open, controlled single-center clinical study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 24 Oct 2012 New trial record